MDL Judge Postpones EpiPen Class Action Trial Due To Continuing COVID-19 Pandemic

Mealey's (December 18, 2020, 12:54 PM EST) -- KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on Dec. 16 “reluctantly” agreed to postpone an April 13 class action trial due to the continuing COVID-19 pandemic (In Re:  EpiPen [Epinephrine Injection, USP] Marketing, Sales Practices and Antitrust Litigation, MDL Docket No. 2785, No. 17-md-2785, D. Kan.)....